Sun pharma expects to stabilize India business in FY19
Favorable demographics conditions will help the company to ensure reasonable volume growth in India Sun Pharmaceutical Industries is excepting its India business to stabilise in the current fiscal leading to reasonable volume growth since company has witnessing disruptions in 2017-18 due to Goods and Services Tax (GST) implementation. However, favorable demographics conditions will help the … Read more
